Skip to main content
Jerome Parnell II, MD, Urology, Raleigh, NC

JeromePParnellIIMD

Urology Raleigh, NC

Physician

Dr. Parnell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Parnell's full profile

Already have an account?

  • Office

    5017 Stoneridge Dr
    Raleigh, NC 27612
    Phone+1 919-986-9117

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 1977 - 1979
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Surgery, 1974 - 1977
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 1974

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1981 - 2025
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • Paysign and ImmunoTek Collaborate in Support of COVID-19 Convalescent Plasma Collection
    Paysign and ImmunoTek Collaborate in Support of COVID-19 Convalescent Plasma CollectionDecember 10th, 2020
  • Emergent BioSolutions, Mount Sinai Health System, and ImmunoTek Bio Centers to Develop COVID-HIG Candidate
    Emergent BioSolutions, Mount Sinai Health System, and ImmunoTek Bio Centers to Develop COVID-HIG CandidateJuly 9th, 2020
  • Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense Funding
    Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers Form Collaboration to Develop Emergent’s COVID-19 Hyperimmune Globulin (COVID-HIG) Product Candidate with U.S. Department of Defense FundingJuly 8th, 2020

Professional Memberships